Maywufa CoTPE:1731 86 EV-to-FCF is 13.60 as of Jul. 12, 2026, which is 59% above its 10-year median of 8.57. GuruFocus rates TPE:1731 with a GF Score™ of 86/100 and a GF Value™ of NT$26.79 (Modestly Undervalued). The stock has 5 warning signs investors should review. Among 562 Drug Manufacturers companies, Maywufa Co ranks better than 66.19% on this metric.
EV-to-FCF is calculated as enterprise value divided by its free cash flow. As of today, Maywufa Co's Enterprise Value is NT$2,766 Mil.
Maywufa Co's Free Cash Flow for the trailing twelve months (TTM) ended in Dec. 2025 was NT$203 Mil. Therefore, Maywufa Co's EV-to-FCF for today is 13.60.
The historical rank and industry rank for Maywufa Co's EV-to-FCF or its related term are showing as below:
TPE:1731'
s EV-to-FCF Range Over the Past 10 Years
Min: -1474.89 Med: 8.57 Max: 137.79
Current: 13.6
During the past 13 years, the highest EV-to-FCF of Maywufa Co was 137.79. The lowest was -1474.89. And the median was 8.57.
TPE:1731's EV-to-FCF is ranked better than 66.19% of 562
companies
in the Drug Manufacturers industry
Industry Median: 20.955
vs TPE:1731: 13.60
EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
Maywufa Co's share price for today is NT$20.65.
Maywufa Co's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was NT$1.350.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Free Cash Flow is an important financial metric because it represents the actual amount of cash at a company's disposal. Companies with a low EV-to-FCF ratio, combined with a strong balance sheet are generally considered as undervalued.
Maywufa Co EV-to-FCF Related Terms
Maywufa Co EV-to-FCF Historical Data
* Premium members only.
The historical data trend for Maywufa Co's EV-to-FCF can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Drug Manufacturers - Specialty & Generic subindustry, Maywufa Co's EV-to-FCF, along with its competitors' market caps and EV-to-FCF data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Maywufa Co EV-to-FCF vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Maywufa Co's EV-to-FCF distribution charts can be found below:
* The bar in red indicates where Maywufa Co's EV-to-FCF falls into.
Maywufa Co's current Enterprise Value is NT$2,766 Mil.
Maywufa Co's Free Cash Flow for the trailing twelve months (TTM) ended in Dec. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was NT$203 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Maywufa Co (TPE:1731) has a EV-to-FCF of 13.60 as of Jul. 12, 2026. EV to FCF ratio is the company's enterprise value divided by free cash flow. View historical data on Maywufa Co and its competitors. This is 59% above median its historical median of 8.57. According to the industry distribution chart, Maywufa Co ranks #190 out of 562 companies in the Drug Manufacturers industry, placing it in the top 33.8%.
Is Maywufa Co's EV-to-FCF too high?
Maywufa Co's current EV-to-FCF of 13.60 is 59% above median its 10-year median of 8.57. The Drug Manufacturers industry median EV-to-FCF is 20.96. Maywufa Co's value of 13.60 is 35.1% below this industry median. Based on the distribution chart, Maywufa Co ranks #190 out of 562 companies in the Drug Manufacturers industry, which is above the industry midpoint. Overall, Maywufa Co has a GF Score™ of 86/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Maywufa Co's EV-to-FCF compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, Maywufa Co ranks #190 out of 562 companies for EV-to-FCF. This puts Maywufa Co in the upper half of its industry. The industry median EV-to-FCF is 20.96. Maywufa Co's value of 13.60 is 35.1% below this benchmark. While the company's 10-year median is 8.57 vs. the industry median of 20.96, Maywufa Co has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-FCF for a Drug Manufacturers company?
The median EV-to-FCF among Drug Manufacturers companies is 20.96, based on 562 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-FCF significantly above this median, while those in the bottom quartile fall well below. However, EV-to-FCF should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Maywufa Co's current EV-to-FCF of 13.60 is 35.1% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-FCF mean?
A high EV-to-FCF can signal that a stock is expensive relative to its fundamentals. EV to FCF ratio is the company's enterprise value divided by free cash flow. View historical data on Maywufa Co and its competitors. For the Drug Manufacturers industry, the median EV-to-FCF is 20.96 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Maywufa Co's current EV-to-FCF is 13.60, which is 59% above median its own 10-year median of 8.57. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Maywufa Co stock overvalued right now?
Based on GuruFocus' analysis, Maywufa Co (TPE:1731) is currently considered Modestly Undervalued. The stock's GF Value™ is NT$26.79, compared to a current price of NT$20.65 — trading 22.9% below its estimated fair value. The current EV-to-FCF is 13.60, which is 59% above median its 10-year median of 8.57 and 35.1% below the Drug Manufacturers industry median of 20.96. Maywufa Co's overall GF Score™ is 86/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-FCF calculated?
EV-to-FCF is calculated from a company's financial statements. For Maywufa Co (TPE:1731), the current EV-to-FCF is 13.60 as of Jul. 12, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Maywufa Co (TPE:1731) Overvalued in 2026?
Based on GuruFocus' analysis, Maywufa Co stock appears to be undervalued.
The current stock price of NT$20.65 is trading 22.9% below its estimated GF Value™ of NT$26.79.
GuruFocus considers Maywufa Co to be Modestly Undervalued.
Key valuation signals for TPE:1731:
EV-to-FCF: 13.60 (59% above median its 10-year median of 8.57)
GF Value™: NT$26.79 vs. price of NT$20.65 (22.9% below fair value)
Industry Position: 35.1% below the Drug Manufacturers median (#190 of 562)
No single metric tells the full story. See the TPE:1731 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Maywufa Co Ltd operates as a drug manufacturer. The company is engaged in manufacturing of hair and skin care products. The company has two reportable segments segments: Management Department, Consumer Business Unit, and Pharmaceutical Business Unit. It derives maximum revenue from Pharmaceutical Business Unit.
86GF Score
Get the complete analysis for TPE:1731
EV-to-FCF is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TPE:1731 has been successfully added to your 
